The Role of Aspirin After High-Risk Percutaneous Coronary Intervention: The Ticagrelor with Aspirin or Alone in High-Risk Patients After Coronary Intervention Clinical Trial Experience.

The Role of Aspirin After High-Risk Percutaneous Coronary Intervention: The Ticagrelor with Aspirin or Alone in High-Risk Patients After Coronary Intervention Clinical Trial Experience. Interv Cardiol Clin. 2020 10; 9(4):489-498.

View in: PubMed

subject areas

Aspirin
Aspirin
Clinical Trials as Topic
Clinical Trials as Topic
Coronary Artery Disease
Coronary Artery Disease
Drug Therapy, Combination
Drug Therapy, Combination
Hemorrhage
Hemorrhage
Humans
Humans
Platelet Aggregation Inhibitors
Platelet Aggregation Inhibitors
Secondary Prevention
Secondary Prevention

authors with profiles

Usman Baber
Zain Ul Abideen Asad